Yuhan USA is a global business development arm of Yuhan Corporation. We are exploring collaborative opportunities and seeking partnerships with global academic research centers, biotech startups, and pharmaceutical companies. Our goal is to identify potential therapeutic assets with validated proof-of-concept data for potential equity investment and in-licensing.
Our Licensing Focus
Our Investment Focus
Since 1926, Yuhan Corporation has upheld its commitment to transparent management and extensive research, striving to develop innovative drugs that positively impact people. With over 300 scientists at Yuhan Research Institute, we are striving to become a patient-centered global leading pharmaceutical company.